{"id": "1350442414922612740", "creation": 1610805536.0, "user_id": "1341014223032238081", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "TNGDA (Doctor's Association) has advised all its members to opt for the Covishield vaccine over Covaxin as the former vector-based vaccine has good immunogenicity and has completed phase 3 of the human trials and published the results.\n\n#toi #covid19 #vaccine https://t.co/OdMPINSju9", "first_save": 1634559108.199414, "hashtags": ["#TOI", "#COVID19", "#VACCINE"]}